MedTrace Logo

A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.

NCT05752123 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2025-03-30

No results posted yet for this study

Summary

This is an open label, single site study to evaluate the safety and Efficacy of ET-01 Transplantation in subjects with Transfusion Dependent β-Thalassaemia.

Conditions

  • Transfusion Dependent Beta-Thalassaemia

Interventions

BIOLOGICAL

ET-01

Recruited participants will receive ET-01 IV infusion after conditioning.

Sponsors & Collaborators

  • The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army

    collaborator OTHER

  • EdiGene (GuangZhou) Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-18
Primary Completion
2024-01-29
Completion
2025-03-12

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05752123 on ClinicalTrials.gov